Drug Search Results
More Filters [+]

AL-54478

Alternative Names: al-54478, al54478, al 54478
Latest Update: 2014-07-31
Latest Update Note: Clinical Trial Update

Product Description

For open-angle glaucoma or ocular hypertension (Sourced from: https://clinicaltrials.gov/ct2/show/NCT01318252)

Mechanisms of Action: EP2 Stimulator

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Alcon
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for AL-54478

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Hypertension|Glaucoma, Open-Angle

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

C-10-080

P2

Completed

Glaucoma, Open-Angle|Hypertension

2011-10-01

Recent News Events

Date

Type

Title